EISENHOWER MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.3M
- Transactions
- 1,517
- Companies
- 40
- Average per transaction
- $4,125
Who reported the payments
| Takeda Pharmaceuticals U.S.A., Inc. | $709,700 |
| Edwards Lifesciences | $685,446 |
| Boston Scientific | $458,381 |
| Janssen Research & Development, LLC | $374,929 |
| Limacorporate S.p.a. | $299,549 |
| Abbott | $292,209 |
| Argenx US, Inc. | $269,440 |
| Stryker | $236,405 |
| Novo Nordisk AS | $216,000 |
| Beigene, Ltd. | $175,111 |
| Viiv Healthcare Company | $172,039 |
| Incyte Corporation | $150,901 |
| Genentech, Inc. | $140,224 |
| Pfizer | $135,653 |
| Gilead | $129,942 |
| Amgen | $129,215 |
| Premia Spine, Ltd. | $106,851 |
| Johnson & Johnson | $104,613 |
| Merck | $103,653 |
| CSL Behring | $100,000 |
| Siemens Medical Solutions USA, Inc. | $98,825 |
| Regeneron | $90,590 |
| Acutus Medical, Inc. | $83,313 |
| AstraZeneca | $74,269 |
| Endotronix, Inc. | $74,183 |
| Biotronik Inc. | $72,997 |
| Smith+Nephew | $70,226 |
| Eli Lilly | $67,458 |
| AbbVie | $60,526 |
| GSK | $58,930 |
| Tersera Therapeutics LLC | $53,961 |
| Olympus America Inc. | $53,654 |
| Medtronic | $51,741 |
| Zimmer Biomet | $42,638 |
| Instrumentation Laboratory Company | $40,020 |
| Spineart SA | $30,300 |
| Beigene USA, Inc. | $27,845 |
| Tandem Diabetes Care, Inc. | $27,200 |
| DJO, LLC | $26,552 |
| Array Biopharma Inc | $25,000 |